Clinical evidence shows users lose nearly 15% of their body weight compared to just 2.4% through lifestyle modifications alone
Although Semaglutide GLP-1 is generally considered safe, it may cause side effects such as nausea, vomiting, diarrhea, constipation, and abdominal discomfort
These findings support the use of metformin in managing pediatric obesity and insulin resistance
While sometimes fruit has been deemed "bad" for weight loss because of its naturally occurring sugars, a 2016 review found that including fruits (namely whole, fresh fruits) in a balanced diet can support weight loss and healthy weight maintenance
Many clinicians therefore use BMI as a screening entry point rather than a verdict, supplementing it with waist circumference, metabolic laboratory values, and a fuller assessment of health status
They are choosing between a treatment available now (tirzepatide) and one that may become available in the next 12 to 18 months (CagriSema)
.png)
